Drug Pipeline

2nd generation SU Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
0
Recruiting
4
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-05-15 NCT07589387 Hypertension Treatment in Nigeria: Hypertension Diabetes Integration Study- Formative Aim… Not Yet Recruiting
Active Studies by Phase
Phase 4
1
Phase 2
1
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07365358 Evaluate the Efficacy and Safety of Empagliflozin or Glimepiride Combination Therapy in… Diabete Type 2 Not Yet Recruiting
Phase 2
NCT06168812 A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer Pancreatic Cancer Active, Not Recruiting
Not specified
NCT05220917 Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in… Cardiovascular Events Active, Not Recruiting
NCT07589387 Hypertension Treatment in Nigeria: Hypertension Diabetes Integration Study- Formative Aim… Diabete Mellitus Not Yet Recruiting
Sponsors Running 2nd generation SU Trials
Brigham and Women's Hospital (1) Memorial Sloan Kettering Cancer Center (1) Chong Kun Dang Pharmaceutical (1) Washington University School of Medicine (1)
Disease Areas
Diabetes (1) Chronic Kidney Disease (1) Pancreatic Cancer (1)
Get alerts when 2nd generation SU trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free